Drug-induced rhythmical activity in the inferior olivary complex of the rat.
Experiments have been performed on pentobarbitone anesthetized or decerebrated rats. The nature of the synchronous rhythmical activity which occurs in the inferior olive following the electrophoretic or systemic administration of harmaline, harmine, dihydro-beta-erythroidine and various other compounds, is described. Harmine was shown to reduce the late phase of biphasic unitary action potentials and to evoke massed synchronous rhythmical activity on which the units were superimposed. The beta-carboline was more effective than ACh or DL-homocysteate (DLH) in increasing cell discharge rates. Synchronized rhythmical activity was recorded more than 500 mum from the site of ejection of the rhythm-inducing drugs. Developed rhythmical activity reduced the size of antidromic field potentials, but antidromic invasion could reset the rhythm of submaximal rhythmical activity. The effects of ACh and DLH, glycine, GABA, NA, DA and 5-HT were tested on established rhythmical activity. Of these, 5-HT was the only compound which almost invariably antagonized the rhythm. A number of tryptamine derivatives and reported 5-HT antagonists, as well as parachlorophenylalanine, have been tested, but the results were largely inconclusive. The hypothesis is advanced that the drug-induced rhythm results from the inhibition of a tonic inhibitory serotonergic input. This antagonism releases an innate tendency of olivary cells to discharge both rhythmically and synchronously.
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001640:Bicuculline / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D010134:Fenclonine / Q000494:pharmacology; D005703:Gallamine Triethiodide / Q000494:pharmacology; D005971:Glutamates / Q000494:pharmacology; D005998:Glycine / Q000494:pharmacology; D006246:Harmaline / Q000494:pharmacology; D006247:Harmine / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D009847:Olivary Nucleus / Q000187:drug effects*; D010424:Pentobarbital / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013331:Strychnine / Q000494:pharmacology; D014363:Tryptamines / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D014403:Tubocurarine / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D005971:Glutamates; D014363:Tryptamines; D012701:Serotonin; D006247:Harmine; D005680:gamma-Aminobutyric Acid; D001285:Atropine; D006246:Harmaline; D013331:Strychnine; D010424:Pentobarbital; D000109:Acetylcholine; D005703:Gallamine Triethiodide; D010134:Fenclonine; D005998:Glycine; D004298:Dopamine; D014403:Tubocurarine; D009638:Norepinephrine; D001640:Bicuculline